Atrium Therapeutics(RNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RNA Atrium Therapeutics

Market Closed 10-09 16:00:00 EDT

8.40

+0.14

+1.69%

盘后8.40

+0.000.00%

19:30 EDT

High8.50	Low8.13	Vol208.35K
Open8.29	D1 Closing8.26	Amplitude4.42%
Mkt Cap143.69M	Tradable Cap132.06M	Total Shares17.11M
T/O1.75M	T/O Rate1.33%	Tradable Shares15.72M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RNA","market":"US","secType":"STK","nameCN":"Atrium Therapeutics","latestPrice":8.4,"timestamp":1791576000000,"preClose":8.26,"halted":0,"volume":208348,"hourTrading":{"tag":"盘后","latestPrice":8.4,"preClose":8.4,"latestTime":"19:30 EDT","volume":2358,"amount":19807.4,"timestamp":1791588606824,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.01694915254237295,"floatShares":15721000,"shares":17105600,"eps":-3.857827,"marketStatus":"Market Closed","change":0.14,"latestTime":"10-09 16:00:00 EDT","open":8.29,"high":8.5,"low":8.1348,"amount":1750550.7300959998,"amplitude":0.044213,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.857827,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":8.26,"preHourTrading":{"tag":"盘前","latestPrice":8.16,"preClose":8.26,"latestTime":"09:10 EDT","volume":690,"amount":5628.8116199999995,"timestamp":1791551441598,"change":-0.1,"changeRate":-0.012107,"amplitude":0.042373},"postHourTrading":{"tag":"盘后","latestPrice":8.4,"preClose":8.4,"latestTime":"19:30 EDT","volume":2358,"amount":19807.4,"timestamp":1791588606824,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5328857748815955,"impliedVol":0.1535,"impliedVolPercentile":0.2632},"requestUrl":"/m/hq/s/RNA/tweets","defaultTab":"tweets","newsList":[{"id":"2674643853","title":"Atrium Therapeutics Corrects Post-Offering Shares Outstanding to 21,571,507","url":"https://stock-news.laohu8.com/highlight/detail?id=2674643853","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674643853?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:18","pubTimestamp":1791541118,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics corrects post-offering shares outstanding to 21,571,507Atrium Therapeutics filed an amended 8-K to correct the previously disclosed post-offering share count.Updated figure: 21,571","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDL8QNrSv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BK4588","RNA","BK4585","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674042200","title":"US Stocks on the MOVE-Palantir, Haemonetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2674042200","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674042200?lang=en_us&edition=fundamental","pubTime":"2026-10-09 02:15","pubTimestamp":1791483328,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Palantir, HaemoneticsOct 8 (Reuters)-US stocks fell on Thursday as a surge in oil prices and Treasury yields near multi-year highs stoked inflation worries before a crucial ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nL6N45U0PE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIN","JZ","09311","BETR","MO","HSIC","DKI","SBFM","LITE","HUT","MANE","PCRX","DVN","PM","CSL.AU","OLED","HAE","PLTR","SBUX","BE","FEDU","CABO","IONQ","RIOT","RCL","AMTD","COHR","GLAS","MARA","STZ","CVX","FLYE","CMG","VTRS","CSGP","OXY","APLD","GNRC","GFS","HUBS","PEP","SXTC","XOM","COP","HNRG","LEVI","AIXI","HELE","RNA","GDDY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074622","title":"Atrium Therapeutics Rallies After $50 Mln Equity Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074622","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074622?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:55","pubTimestamp":1791460513,"startTime":"0","endTime":"0","summary":"BUZZ-Atrium Therapeutics rallies after $50 mln equity raise** Heart drug developer Atrium TherapeuticsRNA.Oshares rising 11.3% to $8.83 before the bell on Thurs after securing $50 mln raise** Biopharm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nL6N45U0QT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Atrium Therapeutics Rallies After $50 Mln Equity Raise","news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","RNA","BK4585","BK4139","BK4505","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673071748","title":"Atrium Therapeutics announces $50M private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2673071748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673071748?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:30","pubTimestamp":1791459017,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics (RNA) announced that it has entered into a securities purchase agreement with a group of institutional investors for a private ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atrium-therapeutics-announces-50m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atrium-therapeutics-announces-50m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4505","BK4585","BK4007","BK4588","RNA","BK4539","LENZ","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673076324","title":"Atrium Therapeutics Prices USD 50 Million Private Placement at USD 7.93 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2673076324","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673076324?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:31","pubTimestamp":1791455469,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics prices USD 50 million private placement at USD 7.93 per shareAtrium Therapeutics priced an unregistered $50 million private placement, expected to close on or about Oct. 9, 2026.De","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL4R0wVX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345777147.USD","BK5152","LU0047473722.SGD","LU0550127509.SGD","LU0575583348.USD","LU1035777561.USD","MNSH","LU0964806797.USD","LU0345770308.USD","LU1791807156.HKD","LU0048578792.EUR","LU0345770993.USD","LU1078025761.USD","BK4585","LU2646069778.SGD","BARC.UK","LU1023061473.USD","LU0171281750.USD","LU0987226296.USD","LU1064927863.SGD","LU0997586606.USD","LU1668664300.SGD","BK4505","IE0004091025.USD","LU1015430645.USD","BK4207","IE00B3T34201.USD","BK4139","LU1023061713.HKD","LU0047473722.EUR","BK4588","LU0161305163.EUR","LU0106831901.USD","IE0004086264.USD","LU0345777659.USD","IE0009354923.USD","RNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673870076","title":"Atrium Therapeutics Announces $50 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2673870076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673870076?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:30","pubTimestamp":1791455400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA6YPRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4505","BK4585","BK4139","IE0009354923.USD","RNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673607680","title":"Atrium Therapeutics - Net Proceeds and Existing Cash Expected to Fund Operations Through 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2673607680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673607680?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:30","pubTimestamp":1791455400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA6YPRM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","BK4585","BK4588","RNA","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673405102","title":"PacBio, TychoBio collaborate to generate full-length RNA data","url":"https://stock-news.laohu8.com/highlight/detail?id=2673405102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673405102?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:35","pubTimestamp":1791293725,"startTime":"0","endTime":"0","summary":"PacBio (PACB) and TychoBio announced a collaboration to generate full-length RNA data that TychoBio will use to train models for RNA therapy design...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pacbio-tychobio-collaborate-to-generate-full-length-rna-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pacbio-tychobio-collaborate-to-generate-full-length-rna-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RNA","BK4588","BK4505","BK4585","IE0009354923.USD","PACB","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673999055","title":"Cerenome Launches CNSide® CSF Molecular Profile Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2673999055","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673999055?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:30","pubTimestamp":1791286200,"startTime":"0","endTime":"0","summary":"New DNA and RNA tests expand CNSide beyond leptomeningeal metastases to molecular profiling across CNS oncologyHOUSTON, Oct.  06, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/06/3375350/0/en/cerenome-launches-cnside-csf-molecular-profile-tests.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSF","BK4139","IE0009354923.USD","BK4588","BK4505","BK4585","RNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672163957","title":"Abogen announces licensing, option agreement with Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672163957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672163957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:10","pubTimestamp":1790935812,"startTime":"0","endTime":"0","summary":"Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing and option agree...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","RSPH","BBP","SYNB","RNA","FHLC","FWD","IE0009354923.USD","BK4505","JDOC","AGNG","XT","DARP","BK4139","LNGR","BK4585","IBB","BK4588","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671209521","title":"Press Release: Wave Life Sciences Announces GSK's Selection of siRNA Program to Transition to GSK for Further Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2671209521","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671209521?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:30","pubTimestamp":1790767800,"startTime":"0","endTime":"0","summary":"Candidate selected by GSK utilizes Wave's best-in-class SpiNA design siRNA and triggers a milestone payment to Wave; three additional collaboration programs advancingCAMBRIDGE, Mass., Sept. 30, 2026 (","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA","BK4099","BK4585","BK4604","TM","BK4232","WVE","BK4022","BK4555","IE0009354923.USD","BK4139","BK4588","BK4007","BK4505","03160","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669948522","title":"ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor","url":"https://stock-news.laohu8.com/highlight/detail?id=2669948522","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669948522?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:00","pubTimestamp":1790164800,"startTime":"0","endTime":"0","summary":"Appointments support ProQR’s strategy to scale AI across the discovery and development of medicines using its Axiomer RNA editing platform and pipelineAX-0811, the first ProQR program identified throu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/23/3367434/33039/en/proqr-announces-appointment-of-chris-hart-as-chief-data-and-ai-officer-and-thomas-wolf-to-join-the-board-of-directors-as-strategic-ai-advisor.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","LU1721428933.USD","BK4106","VTHR","LU2041044095.USD","QTOC","LU1166156734.SGD","BK4567","LU2229751404.USD","RNA","IE0009354923.USD","LU2092937221.SGD","BK4121","AIPO","BK4505","LU1165135440.EUR","LU2089279066.USD","IE00BN0W2V16.EUR","LU0347712357.USD","G","BK4139","BK4523","LU0702159343.USD","LU1721429402.USD","BK4226","BK4585","IE00BN0W2T93.GBP","LU2413666699.HKD","LU2413666426.HKD","IE00BN0W2W23.USD","A","LU1721429741.USD","BK4588","AGIX","LU0702159699.USD","LU1543694498.USD","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669514991","title":"Press Release: Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669514991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669514991?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:30","pubTimestamp":1790076600,"startTime":"0","endTime":"0","summary":"Dr. Vnuk brings substantial business and corporate development leadership experience from Sanofi, Blackstone, and PfizerCAMBRIDGE, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Na","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4139","IE0009354923.USD","RNA","BK4505","BK4232","R","WVE","BK4022","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669090198","title":"Atrium Therapeutics Awards New Hire Options for 13,500 Shares, RSUs for 6,750 Shares Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2669090198","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669090198?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:30","pubTimestamp":1790022657,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics awards new hire options for 13,500 shares, RSUs for 6,750 shares under inducement planAtrium Therapeutics awarded inducement equity grants on Sept. 20, 2026 to one newly hired non-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL1jbvXC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","BK4585","BK4588","RNA","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669198084","title":"Atrium Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669198084","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669198084?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:30","pubTimestamp":1790022600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUABMX93N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNA","BK4505","BK4139","BK4588","IE0009354923.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669185169","title":"Alzheimer’s-Fighting ADARx Pharmaceuticals Set for Near $2B IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669185169","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669185169?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:46","pubTimestamp":1789998403,"startTime":"0","endTime":"0","summary":"ADARx Pharmaceuticals, which is using RNA technology to fight diseases like Alzheimer’s, is targeting a valuation of up to $1.74 billion in its U.S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/alzheimers-fighting-adarx-pharmaceuticals-set-for-near-2b-ipo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/alzheimers-fighting-adarx-pharmaceuticals-set-for-near-2b-ipo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","TACU","REDS","CDIG","FRHC","IE0009354923.USD","KCE","BK4139","BK4127","IPOS","TSPA","RNA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668641659","title":"FMC, AgroSpheres advance bioinsecticide pipeline into field trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2668641659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668641659?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:50","pubTimestamp":1789645827,"startTime":"0","endTime":"0","summary":"AgroSpheres and FMC (FMC) Corporation announced ab advancement in its ongoing collaboration. Two proprietary RNA-based biomolecule candidates from ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fmc-agrospheres-advance-bioinsecticide-pipeline-into-field-trials-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fmc-agrospheres-advance-bioinsecticide-pipeline-into-field-trials-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","RNA","BK4588","BK4585","LU0385154629.USD","BK4139","BK4545","IE0009354923.USD","FMC","LU0471298777.SGD","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667198938","title":"Pharma Sector Doubles Down on AI to Slash Costs, Timelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2667198938","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667198938?lang=en_us&edition=fundamental","pubTime":"2026-09-16 21:53","pubTimestamp":1789566783,"startTime":"0","endTime":"0","summary":"FACTBOX-Pharma sector doubles down on AI to slash costs, timelinesSept 16 (Reuters)-Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate research and development,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4N4580T8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069347547.HKD","BK4527","LU0889566641.SGD","LU1228905037.USD","LU2028103732.USD","LU0211327993.USD","LU0276348264.USD","SGXZ51526630.SGD","LU1119994496.HKD","LU0912757837.SGD","NVDL","SG9999017495.SGD","IYH","LU2326559502.SGD","ELIS","LU2362541273.HKD","LU1496350171.SGD","SGXZ23171101.USD","LU0057025933.USD","LU1064131342.USD","LU0823434583.USD","LU1228905540.USD","LU2506952097.USD","NVII","LU0642271901.SGD","LU2265009873.SGD","BK4077","LU2360032135.SGD","LU1003076772.USD","IE00BFSS8Q28.SGD","LU0203201768.USD","LU1934455194.USD","MSFO","SG9999013999.USD","LU0289961442.SGD","LU1941712348.USD","LU2322448791.USD","LU0097036916.USD","LU1093756168.USD","LU1868837300.USD","LU1929549753.HKD","WISE","XLK","LU2361044949.HKD","LU1699723380.USD","BK4538","LU2191332357.HKD","NVD3.UK","CLSE","LU2394011477.USD","SG9999001176.SGD","LU0823421333.USD","LU2896262040.SGD","BK4134","LU0648000940.SGD","LU0390134368.USD","LU1582986359.USD","LU0077335932.USD","LU1116320737.USD","LLII","LU0823421416.USD","LU0211326839.USD","LU2543165471.USD","LU1221951046.USD","LU2133065610.SGD","BK4141","LU2125154778.USD","LU2430703178.SGD","CANC","LU0314106906.USD","LU1868836757.USD","09388","GB00B4LPDJ14.GBP","LU1244550577.SGD","LU0476273544.USD","LU0683600562.USD","BK4612","LU2125909916.SGD","PFE","LU2471134796.USD","LU2236285917.USD","IE0005OL40V9.USD","LU1935043452.HKD","LU2054465674.USD","LU1435385759.SGD","LU0128526141.USD","LU0417517546.SGD","LU1983299246.USD","IE00BK4W5M84.HKD","LU0823414551.USD","IE00BZ1G4Q59.USD","LU0823434740.USD","IE00BN29S564.USD","LU2357125470.USD","LU2023250330.USD","XDAT","LU1196500208.SGD","LU2148611432.USD","LU1585245621.USD","LU0345770993.USD","LU0898699433.AUD","LU1481599808.USD","LTL","LU1880398471.USD","LU0997586515.USD","LU1951200564.SGD","LU2462591350.SGD","LU0942090050.USD","LU2097344357.USD","LU2491050154.USD","BK4579","VHT","IE000SO60NU8.SGD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU1019632923.USD","LU1988902786.USD","SG9999018865.SGD","LU0225283273.USD","LU0267386448.USD","LU0306806265.USD","LU1803068623.USD","CHAT","LU0289739699.SGD","NVDD","SG9999000418.SGD","LU2108987350.USD","TMED","LU2279689827.SGD","SG9999014575.USD","LU0354030438.USD","LU0950375773.USD","LU1366192091.USD","IE00BN8TJ469.HKD","LU2242646821.SGD","LU0889565916.HKD","IE0034235188.USD","LU2168564065.EUR","LU0456855351.SGD","LU2210150020.SGD","LU2552382215.SGD","BK4532","LU2097829019.USD","IE00BVYPNW00.USD","CNEQ","LU1019634622.SGD","LU2491050071.SGD","LU0061474960.USD","LU0640476718.USD","LU1188199696.SGD","IE00B3T34201.USD","LU1273509221.SGD","LU0171276677.USD","LU2750360641.GBP","IE00BJJMRZ35.SGD","NVDA","LU2462157665.USD","AZN.UK","IE00B19Z8W00.USD","LU0347712357.USD","IE00BKDWB100.SGD","MSFU","IE00B4JS1V06.HKD","LU2092937148.SGD","IE0009G5SDU7.USD","LU2298321311.HKD","LU0138981039.USD","LU0079474960.USD","INCY","LU0107464264.USD","LU0320765992.SGD","MHIP","BK4550","LU0972486137.USD","SG9999015952.SGD","MSFX","IE00BJTD4N35.SGD","LU1046234339.USD","LU2381873111.SGD","LU1564329628.SGD","LU1720051108.HKD","LU1861215975.USD","LU2125909759.SGD","LU0157215616.USD","LU1078025761.USD","BK4528","LU1121112475.USD","LU1854104046.USD","LU2168564222.USD","LU2404859741.USD","LU0784385170.HKD","ESUM","LU0048573561.USD","LU0528227936.USD","LU1144417596.USD","LU1181866309.USD","LU0320765646.SGD","LU0114720955.EUR","LU2355687059.USD","LU2089984988.USD","BK4551","LU0985481810.HKD","HK0000914686.HKD","LU0672654240.SGD","LU1732799900.SGD","LU2065171402.SGD","NVDS","LU0345768740.USD","LU2168563687.JPY","BK4505","IQV","LU3187612489.SGD","VGT","PPH","BK4577","IE00B3PB1722.GBP","IE00BKPKM429.USD","BK4568","LU2250418816.HKD","LU0302445910.USD","LU2065170008.USD","NULC","LU1235294995.USD","IE00BMPRXR70.SGD","BK4529","IE00B7SZLL34.SGD","IE00BDGV0183.EUR","IE0002270589.USD","IE0009354923.USD","IE00B66KJ199.SGD","LU0726765562.USD","BK4533","IE00BWXC8680.SGD","LU0784383803.USD","LU1093756325.SGD","LU1923622291.USD","BK4504","LU1035775433.USD","LU2271345857.HKD","ILDR","LU0321505439.SGD","LU0321505868.SGD","LU2272731865.HKD","LU0215105999.USD","RNA","IE00BZ199S13.USD","LU2098885051.SGD","LU1316542783.SGD","LU2272731782.SGD","LU2458330169.SGD","BK4574","LU1153584641.USD","LU2491049909.HKD","BK4608","LLY","LU1170363599.USD","TYLG","IE000F7OJYX1.SGD","LU0871640123.AUD","SNVD.UK","HK0000306701.USD","IE00B19Z9505.USD","LU1481600234.SGD","WDNA","MSFY","BK4567","GOOL","LU2471134879.HKD","MEDI","NVD","IE0004445239.USD","LU0894485498.HKD","LU2129689431.USD","LU2112291526.USD","LU2322448957.HKD","LU0289941410.SGD","LU0056508442.USD","LU0943347566.SGD","SMHX","FTEC","LU1032955483.USD","LU1863844665.USD","LU0345768153.USD","LU2237957811.SGD","LU0444971666.USD","GNMX","LU0949170772.SGD","SKYY","FHLC","LU0211331839.USD","BK4566","HK0000914660.USD","LU2362540622.SGD","LU0053666078.USD","LU1935042488.USD","LU0784384876.USD","LU2347655156.SGD","GOOW","LU1267930573.SGD","SG9999015945.SGD","BK4592","LU0788109477.HKD","LU1880398554.USD","LU1934455863.HKD","LU0545562505.USD","LU1633808545.USD","LU2361045086.USD","LU0792757196.USD","LU0203347892.USD","LU2106854487.HKD","BK4543","LU2237443895.HKD","LU2023250504.SGD","SG9999001077.SGD","LU1629891620.HKD","CQTM","LU2458330243.SGD","09788","IE00BGHQF631.EUR","LU0861579265.USD","LU1815336760.USD","IE00BDCRKT87.USD","LU2249611893.SGD","LU0094547139.USD","LU0757359954.USD","LU1821325948.USD","TDIV","LU1992135472.HKD","TEK","LU2100268510.USD","IE00B19Z4B17.USD","LU1814569148.SGD","LU1670627923.USD","LU2860962120.EUR","SLP","IE00B7KXQ091.USD","LU0994945656.USD","GB00B4QBRK32.GBP","IE0002141913.USD","LU0237698245.USD","GOGL","BK4534","EKG","GB00BDT5M118.USD","BK4561","BK4548","LU0070217475.USD","LU0494093205.USD","LU0708995401.HKD","BK4196","LU1861127337.USD","ANV","LU2361044865.SGD","XLC","LU2237443978.SGD","BK5011","OGIG","LU0080751232.USD","LU1496350502.SGD","TRFK","LU1015430645.USD","LU0122379950.USD","IE0003U64NQ7.SGD","LU2023250843.SGD","EFIV","LU2095319765.USD","LU1201861165.SGD","HK0000532082.HKD","SG9999003800.SGD","LU1066051225.USD","LU1236620834.HKD","LU0175139822.USD","IE0034235295.USD","LU0174119429.USD","LU1863844749.USD","LGHT","SGXZ80539844.SGD","LU0348723411.USD","LU1201861249.SGD","IE000M9KFDE8.USD","LU2954938101.SGD","LU1242518931.SGD","LU1645745479.HKD","LU0187121727.USD","LU1506573853.SGD","NVDW","SMH","IE0004445015.USD","LU1935042215.USD","LU1430594728.SGD","TRUH","LU0868494617.USD","LU0256863811.USD","LU0969580561.USD","THMR","LU0823416689.USD","LU1064927863.SGD","LU1244550494.USD","LU0957799991.USD","LU0795875086.SGD","IE00BYQQ9H92.USD","LU0081259029.USD","LU0472753341.HKD","USD","AIPI","LU1880407132.USD","BK4614","CMAG","LU1670711123.USD","LU0143551892.USD","LU0432979614.USD","LU1839511570.USD","LU2360108059.USD","LU2102340556.USD","LU2462591277.SGD","LU1323610961.USD","BK4559","LU1974910355.USD","LU0820561909.HKD","LU0006306889.USD","BK4167","LU0757432116.USD","LU1670710661.SGD","BK4535","LU1340139317.AUD","GGLL","IE000MB6IJN5.SGD","LU2471134952.CNY","LU0306807586.USD","SG9999002232.USD","SDGR","NVD2.UK","LU0957808578.USD","HK0000304805.HKD","LH","LU0353189763.USD","LU2063271972.USD","PAWZ","IE000Q6AESB8.SGD","IE00BK4W5L77.USD","LU2168564495.EUR","LU2756315318.SGD","MSFL","TTEQ","LU0786609619.USD","LU0310799852.SGD","LU0964807845.USD","LU0882574055.USD","LU2244417387.USD","LU0859254822.USD","LU2092627202.USD","GOOGL","LU1571399168.USD","SG9999014880.SGD","GOOP","LU1127390331.HKD","LU0149725797.USD","LU0289960550.SGD","LU2264538146.SGD","SOXX","LU0266013472.USD","BK4581","LU0061475181.USD","LU2237443622.USD","LU2750360997.AUD","LU0072462426.USD","SG9999001424.SGD","SG9999015358.SGD","FMED","LU0965508806.USD","LU2041044095.USD","FCOM","LU0894486033.HKD","LU3102509885.SGD","SGXZ44715902.SGD","LU0234570918.USD","LU1267930227.SGD","LU1923621640.USD","LU0920783379.SGD","ELIL","LU2125154935.USD","LU1582986433.USD","LU2294711713.HKD","LU2089985449.USD","SG9999015986.USD","IE00BMPRXQ63.HKD","LU1868836914.USD","LU2746668974.SGD","LU0385154629.USD","LU0058720904.USD","LU0310800965.SGD","LU2087621335.USD","LU0820562030.AUD","LU0133085943.USD","NVDG","LU0130102774.USD","LU1868837136.USD","LU1674673691.USD","LU2168564149.EUR","LU2404859667.USD","LU1303367103.USD","MSFT","HK0000306685.HKD","LU0444973449.USD","AGOX","LU2456880835.USD","BK4007","BK4585","BK4605","RSPS","LU1400636574.HKD","LU2433249047.HKD","LU0690374615.EUR","LU1366333091.USD","LU0096364046.USD","LU0225771236.USD","LU1487256676.USD","IE00BD6J9T35.USD","LU1670711040.USD","GDOC","BK4516","LU0251131958.USD","LU1732800096.USD","IE00BBT3K403.USD","HEAL","LU1291159041.SGD","GAMR","LU0690374961.EUR","GOOX","LU2746668461.USD","LU0345777147.USD","IHE","LU0158827781.USD","LU1670628061.USD","03165","LU0511384066.AUD","LU1989763005.USD","LU0738911758.USD","BK4121","LU1778281490.HKD","LU1721428933.USD","LU2360106947.USD","IE00B3S45H60.SGD","LU2129689605.HKD","KVUE","LU2211815571.USD","LU0965509010.AUD","LU0314104364.USD","SG9999001440.SGD","LU1923622614.USD","LU0395794307.EUR","NVC","LU1941712264.USD","IE00B1BXHZ80.USD","3NVD.UK","LU1935042991.SGD","LU2092937221.SGD","LU0316494557.USD","LU1861220033.SGD","LU2210149790.SGD","LU2237443382.USD","BK4097","LU1720051017.SGD","LU0210536198.USD","USXF","IE00BLSP4239.USD","LLYX","LU1242518857.USD","IE00B4YYXB79.USD","LU0162691827.USD","LU0960981461.USD","LU1066051811.HKD","IGV","MSFW","LU0072461881.USD","IE00B775H168.HKD","GNOM","IE0004091025.USD","IE000ITXATA3.USD","LU1642822529.SGD","LU2077746001.SGD","LU2237443465.HKD","IE0009355771.USD","SG9999014914.USD","LU0345774631.USD","LU1917777945.USD","ROM","OZEM","LU1564329115.USD","LU1674673428.USD","SG9999001176.USD","LU1582987597.SGD","HK0000320223.HKD","LU0868494708.USD","LU1037948541.HKD","LU1267930490.SGD","LU0471298777.SGD","LU2286300806.USD","LU0742534661.SGD","DIPS","LFGY","LU1244550221.USD","LU1914381329.SGD","LU0889565080.SGD","LU2463028550.USD","LU1989764748.USD","LU0345769631.USD","LU1868836591.USD","LU0526926950.USD","JGRO","LU0211326755.USD","LU0274383776.USD","LU2506951792.HKD","LU0354030511.USD","LU1803068979.SGD","LU1069344957.HKD","IE00BJT1NW94.SGD","LU2324357040.USD","LU2272731600.USD","LLYZ","LU0124676726.USD","LU1935043023.USD","IE00BFXG0V08.USD","LU1280957306.USD","IE0000B7K699.USD","NVDX","LU0640478417.SGD","LU2129689514.USD","2NVD.UK","LU0345769128.USD","LU2764263203.CNY","LU0265550946.USD","BK4514","LU2242649171.HKD","SG9999002224.SGD","SG9999014567.USD","LU0879622024.SGD","IE00BJJMRX11.SGD","LU2087625088.SGD","SGXZ31699556.SGD","SGXZ99366536.SGD","LU0689626769.HKD","LU1718418525.SGD","LU0011850046.USD","LU0098860793.USD","LU2091194634.USD","KD","LU1989773731.SGD","SG9999014906.USD","ARTY","LU2213496289.HKD","IE00BMPRXN33.USD","LU0048584097.USD","LU2065169927.USD","LU0130103400.USD","LU0128525689.USD","BK4554","LU2461242641.AUD","LU1236620750.USD","LU0323240290.USD","FTXH","IE000W1ABFV2.USD","MEDX","IE0004086264.USD","SOXY","LU0980610538.SGD","CURE","LU1992135399.USD","LU2452424414.USD","IE00BFMHRM44.USD","MSFD","IE00BQXX3C00.GBP","07388","LU0096362180.USD","LU2413666426.HKD","LU0198837287.USD","LU0265550359.USD","BK4576","LU2506951875.HKD","XLV","IE00B775SV38.USD","IXJ","LU0210528500.USD","BMY","LU0342679015.USD","LU0426417589.USD","LU0575583348.USD","SG9999015978.USD","IE00BKVL7J92.USD","JDOC","LU0724617625.USD","IE0034235303.USD","GLAM","LU1883839398.USD","LU2293690249.USD","SG9999014542.SGD","RXL","LU0553294199.USD","LU0795875169.SGD","LU2114397693.USD","LU2506952170.USD","LU0345774391.USD","SG9999011175.SGD","LU2764262908.HKD","SG9999014898.SGD","IE00BDRTCR15.USD","LU2357305700.SGD","VT","LU0648001328.SGD","LU1043141123.HKD","LU1894683264.USD","LU1979441026.SGD","MSFC","IE00BQXX3D17.EUR","LU1066053197.SGD","LU2637965513.SGD","LU0557290698.USD","LU0471298694.HKD","LU0052756011.USD","LU0170899867.USD","LU1104425308.USD","LU2756315664.SGD","CHPX","LU2505996681.GBP","SG9999004303.SGD","LU1791710582.SGD","LU0320765489.SGD","LU0979878070.USD","LU1852331112.SGD","LU1074936037.SGD","LU0499090636.EUR","IE00BKPKM643.USD","LU1202635105.USD","LU1235295455.SGD","LU0070302665.USD","BK4549","LU0006061336.USD","LU0820561818.USD","GOOY","LU2089283258.USD","LU1003077747.HKD","IE000KEQY171.SGD","LU0130518102.USD","IE000BZT7R73.USD","LU1221951129.SGD","LU0029874061.USD","LU0238689110.USD","IE0001KFT4U8.USD","BMED","IE00BJLML261.HKD","NVDS.UK","NVDB","BK4588","LU2362541513.USD","LU2413666699.HKD","LU1989772840.SGD","IXN","LU2293690082.USD","LU0787776722.HKD","LU2592432038.USD","TWST","LU2097344431.USD","LU0225284248.USD","PJP","LU2125909593.SGD","JNJ","IE00B5TLWC47.USD","LU1823568750.SGD","LU0256863902.USD","LU1923623000.USD","LU0827474353.SGD","LU2360107168.USD","LU0477156797.USD","SG9999018857.SGD","GOU","LU2275660780.HKD","SGXZ81514606.USD","LU0109394709.USD","LU0154236417.USD","LU0545039389.USD","LU0095938881.EUR","LU1670756490.USD","LU1989764664.SGD","BK4598","BK4139","LU0353189680.USD","LU2430703251.USD","LU2471134523.USD","LU2552382132.HKD","LU0128525929.USD","LU0312595415.SGD","LU1429558221.USD","LU1815333072.USD","LU2237957902.USD","NVYY","BK4599","LU2539964713.USD","HK0000819398.USD","HK0000320264.USD","LU0960925559.SGD","IE000WAW04H5.SGD","LU1267930730.SGD","LU2473716301.USD","FAI","IE00BQXX3F31.USD","LU1829250122.USD","NVDQ","LU0965509101.SGD","LU2125910179.SGD","BK4503","LU0477156953.USD","LU1061106388.HKD","LU0106261372.USD","LU0082616367.USD","NVDO","LU0234572021.USD","LU1043141396.HKD","LU1301847155.USD","LU1400636657.SGD","LU2065171311.SGD","LU1551013425.SGD","GXPC","LU2047632596.USD","MRK","TTXU","LU1232071149.USD","LU2290526834.HKD","TRUC","LU2125909247.SGD","BK4525","NVIW.SI","LU2357627491.SGD","LU0345777659.USD","VOX","ILMN","IETC","LU0211328371.USD","LU0345770308.USD","ARKG","LU0047473722.SGD","LU0251132253.USD","LU1116320901.HKD","LU1670710588.SGD","LU1935043536.SGD","LU1934455277.USD","LU1084165304.USD","SNPE","LU2468319806.SGD","LU1162221912.USD","LU1951198990.SGD","LU2931357623.SGD","LU1400636491.USD","TMO","IE00BFXG1179.USD","LU1582987324.SGD","LU0426412945.USD","LU0823417737.USD","SGXZ57979304.SGD","LU2764263039.SGD","AGNG","SMSFTmain","LU1051770623.HKD","THNR","LU0308772762.SGD","LU0109392836.USD","LU0889565833.HKD","LU0708994859.HKD","LU0965509283.SGD","LU2237438978.USD","ESLG","LU2111349929.HKD","LU2720916845.USD","IE0031619046.USD","METV","LU0061474705.USD","GEHC","LU1267930813.SGD","LU0957791311.USD","LU2237443549.SGD","LU0310800379.SGD","LU1894683348.USD","07788","LU0203202063.USD","LU0466842654.USD","LU1989771016.USD","LU2125910336.SGD","LU2430703095.HKD","LU0661504455.SGD","LU0171293334.USD","SPTE","LU0203345920.USD","IE00B7SZL793.SGD","IE00BYXW3230.USD","IE00B4R5TH58.HKD","LU0323591593.USD","LU1623119135.USD","LU1153585028.USD","LU0208291251.USD","LU0320765059.SGD","LU0997586432.USD","LU0069063385.USD","HRTS","LU1791710400.SGD","LU1564329461.SGD","LU1145028129.USD","LU1261432733.SGD","LU0964806797.USD","SNVDAmain","LU0976567544.SGD","GGLS","LU0823399737.USD","LU1551013342.USD","LU0823414478.USD","SHOC","IE00B2B36J28.USD","LU1057294990.SGD","LU2506951958.HKD","LU1035773651.USD","LU2242650005.HKD","LU0882574139.USD","BK4183","LU1037948897.HKD","LU2999663052.SGD","LU1196032939.SGD","IE00BSNM7G36.USD","IE00B3M56506.USD","LU1066051498.USD","IE00B19Z3B42.SGD","IE00B19Z8X17.USD","LU0719512351.SGD","LU1059921491.USD","LU1032466523.USD","LU0857590862.USD","LU2089284900.SGD","IE00BFSS7M15.SGD","LU2211814178.USD","LU0158827948.USD","IE000YTNTUN2.SGD","LU0289739343.SGD","LU2487616109.SGD","IE00BLSP4452.SGD","LU0109391861.USD","LU2347655073.USD","LU2505996509.AUD","LU1548497426.USD","LU0047473722.EUR","BK4587","IE00B5949003.HKD","LU1989772923.USD","NVDU","ABFL","LU0689472784.USD","LU1804176565.USD","BK4530","LU0949170426.SGD","AIFD","LU1334329650.SGD","LU0823417653.USD","LU1983260115.SGD","LU2552382058.USD","LU1697837992.HKD","LU1854103824.USD","IE0009356076.USD","LU2083900584.USD","BK4573","LU1564329032.USD","LU2420271590.USD","IE00B19Z3581.USD","LU0130517989.USD","LU0985320562.USD","SOXQ","LU0920840948.USD","BK4602","LU0127658192.USD","LU0251142724.SGD","LU1691799644.USD","LU0887340254.USD","LU1355424745.HKD","LU1712237335.SGD","LU2596442595.SGD","LU2242652126.USD","LU0757359368.USD","NVDY","IE00BHPRN162.USD","IE00BVYPNV92.GBP","LU2023251221.USD","IDNA","LU2417539215.USD","LU0963555726.SGD","IE00BFTCPJ56.SGD","LU0210533765.USD","LU0784385840.USD","LU0029864427.USD","SG9999015341.SGD","LU0323239441.USD","FDTX","LU1023059063.AUD","LU2360106780.USD","HK0000304797.USD","IE00B42XCP33.USD","LU1880407215.USD","LU2403377893.USD","IE00BJTD4V19.USD","LU2247934214.USD","LU2602419157.SGD","LU0496365809.HKD","LU1046421795.USD","SG9999014559.SGD","IE00B3SWFQ91.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666162533","title":"ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666162533","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666162533?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept.  09, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358547/33039/en/proqr-announces-first-participant-dosed-in-phase-1-study-of-ax-0811-and-virtual-investor-and-analyst-educational-event-on-september-30-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2413666699.HKD","LU1543694498.USD","RNA","LU1861217088.USD","BK4195","KBWY","BK4567","LU2360107671.USD","A","IE00BN0W2V16.EUR","BK4585","LU1165135440.EUR","LU1721428933.USD","LU2229751404.USD","BK4211","BK4121","BK4139","LU1721429741.USD","BK4023","LU2092937221.SGD","IE0009354923.USD","LU1861220207.SGD","LU2413666426.HKD","LU0702159343.USD","IE00BN0W2T93.GBP","BK4505","BK4226","BK4523","G","IE00BN0W2W23.USD","PK","PD","BK4106","BK4181","LU1166156734.SGD","BK4588","LU0702159699.USD","LU0347712357.USD","BK4218","LU1169590202.USD","LU2089279066.USD","LU1721429402.USD","LU2041044095.USD","LU1169589451.USD","AX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378421","title":"GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378421","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378421?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:15","pubTimestamp":1788869700,"startTime":"0","endTime":"0","summary":"New whole blood RNA sequencing data identified coordinated, consistent change in genes governing immune re-balancing, myofibroblast inhibition, fibrolysis, basement membrane repair, re-epithelializati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357628/0/en/gri-bio-presents-new-phase-2a-data-at-ers-2026-defining-gri-0621-s-mechanism-of-action-in-ipf-across-nine-mechanistic-pillars.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4505","GRI","RNA","IE0009354923.USD","FVC","BK4585","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atriumtherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0714},{"period":"1month","weight":-0.2008},{"period":"3month","weight":-0.3258},{"period":"6month","weight":-0.3391},{"period":"1year","weight":-0.5333},{"period":"ytd","weight":-0.5333}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.0313},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1417}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease is under phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of Duchenne Muscular Dystrophy, which is under phase 1/2 clinical trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy is in phase 1/2 clinical trial. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.025613},{"month":2,"riseRate":0.666667,"avgChangeRate":0.084173},{"month":3,"riseRate":0.4,"avgChangeRate":-0.00029},{"month":4,"riseRate":0.4,"avgChangeRate":-0.058331},{"month":5,"riseRate":0.4,"avgChangeRate":-0.018927},{"month":6,"riseRate":0.8,"avgChangeRate":0.113151},{"month":7,"riseRate":0.5,"avgChangeRate":0.027674},{"month":8,"riseRate":0.666667,"avgChangeRate":0.073003},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.048121},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.000506},{"month":11,"riseRate":0.666667,"avgChangeRate":0.096576},{"month":12,"riseRate":0.666667,"avgChangeRate":0.110632}],"exchange":"NASDAQ","name":"Atrium Therapeutics","nameEN":"Atrium Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atrium Therapeutics(RNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Atrium Therapeutics(RNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Atrium Therapeutics,RNA,Atrium Therapeutics股票,Atrium Therapeutics股票老虎,Atrium Therapeutics股票老虎国际,Atrium Therapeutics行情,Atrium Therapeutics股票行情,Atrium Therapeutics股价,Atrium Therapeutics股市,Atrium Therapeutics股票价格,Atrium Therapeutics股票交易,Atrium Therapeutics股票购买,Atrium Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atrium Therapeutics(RNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Atrium Therapeutics(RNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}